REFERENCES
  1. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, COVID-19 (SARS-CoV-2 ENFEKSİYONU) REHBERİ. 14 NİSAN 2020.https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf.
  2. Infection prevention and control during health care when COVID-19 is suspected, interim guidance. WHO reference number: WHO/2019-nCoV/IPC/2020.3.
  3. Epidemiological Group of Emergency Response Mechanism of New Coronavirus Pneumonia of Chinese Centre for Disease Control and Prevention. Analysis of Epidemiological Characteristics of New Coronavirus Pneumonia [J] . Chinese Journal of Epidemiology, 2020, 41 (02): 145-151.DOI: 10.3760 /cma.j.issn.0254-6450.2020.02.003
  4. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China [J]. Lancet Oncol, 2020. pii: S1470-2045 (20) 30096-6. DOI: 10.1016 / S1470-2045 (20) 30096-6.
  5. Yang L, Xu HY, Wang Y. Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19). Zhonghua Zhong Liu Za Zhi. 2020 Mar 2;42(0):E006. doi: 10.3760/cma.j.cn112152-20200229-00152. [Epub ahead of print] Chinese.
  6. Xu Y, Liu H, Hu K Wang M. Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19). Zhongguo Fei Ai Za Zhi. 2020 Mar 20;23(3):136-141. doi: 10.3779/j.issn.1009-3419.2020.03.02. Epub 2020 Feb 20.
  7. Yue D, Xu S, Wang Q, et al. OA 16.04 Efficacy and safety of erlotinib vs vinorelbine / cisplatin as adjuvant therapy for stage ⅢA EGFR mutant NSCLC patients [J]. J Thorac Oncol, 2017, 12 (11): S1789. DOI: 10.1016 / j.jtho.2017.09.423.
  8. Du Y, Tu L, Zhu P3 Mu M, Wang R, Yang P et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study. Am J Respir Crit Care Med. 2020 Apr 3. doi: 10.1164/rccm.202003-0543OC.
  9. Zhang, F. Zhu, L. Xie, C. Wang, J. Wang, R. Chen, P. et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Annals of Oncology (2020), doi:https://doi.org/10.1016/j.annonc.2020.03.296
  10. Qu J, Yang R, Song L, Kamel IR. Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19. Ann Oncol. 2020 Mar 9. pii: S0923-7534(20)36080-4. doi: 10.1016/j.annonc.2020.03.001
  11. Polverari G, Arena V, Ceci F, Pelosi E, Ianniello A, Poli E et al. 18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging. J Thorac Oncol. 2020 Mar 31. pii: S1556-0864(20)30286-0.
  12. Zhu J, Zhong Z, Li H, Ji P, Pang J, Li B et al. CT imaging features of 4121 patients with COVID-19: A meta-analysis. J Med Virol. 2020 Apr 21. doi: 10.1002/jmv.25910.
  13. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020 Mar 17;9(1):29.
  14. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020 Feb 26:200642.
  15. Bonomi L, Ghilardi L, Arnoldi E, Tondini CA, Bettini AC. A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab. J Thorac Oncol. 2020 Mar 31. pii: S1556-0864(20)30285-9. doi: 10.1016/j.jtho.2020.03.021